Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Hypertension. 2018 Jun 18;72(2):451–459. doi: 10.1161/HYPERTENSIONAHA.118.11161

Table 2.

Primary maternal-fetal outcomes in patients with r-AKI vs no AKI.

Outcome r-AKI (N=246) No AKI
N=14,240
Unadjusted Odds Adjusted Odds
Stage 1
N=98
Stage 2
N=99
Stage 3
N=49
Maternal Outcomes
Cesarean section 38% (94) 31% (4,430) 1.4 [1.1-1.8] 1·3 [0.9-1.9] p=0.190
36% (35) 40% (40) 39% (19)
Preeclampsia 22% (55) 9% (1,274) 3.0 [2.2-4.0] 2·9 [1.9-4.4] p<0.001
12% (12) 23% (23) 40% (20)
Preterm Preeclampsia (<37 weeks) 9% (22) 2% (330) 4.1 [2.6-6.5] 3·6 [1.8-7.1] p<0.001
4% (4) 9% (9) 18% (20)
Early Preterm Preeclampsia (<34 weeks) 4% (9) 1% (95) 5.7 [2.8-11.3] 1·2 [0.2-8.7] p=0.878
1% (1) 4% (4) 8% (4)
Gestational Hypertension 22% (51) 12% (1,621) 2.0 [1.5-2.7] 2.3 [1.7-3.3] p<0.001
12% (12) 25% (24) 33% (15)
Fetal Outcomes
Gestation age at delivery – weeks 38.2±3.0 39.0±22 n/a n/a p<0.001
38.7±2.4 38.1±3.3 37.1±3.5
Baby weight – grams 3,010±690 3,350±620 n/a n/a p<0.001
3,240±600 3,040±730 2,940±730
Birth weight <10th percentile 20% (50) 9% (1,299) 2.5 [1.8-3.5] 2.7 [1.7-4.3] p<0.001
16% (16) 24% (24) 20% (10)
Birth weight <5h percentile 9% (23) 5% (718) 1.5 [0.9-2.4] 2.2 [1.4-3.4] p=0.001
7% (7) 10% (10) 12% (6)
Birth weight <3rd percentile 3% (8) 3% (397) 1.2 [0.6-2.4] 1.3 [0.6-2.6] p=0.495
*** *** ***
Perinatal Death **** 1% (108) 2.2 [0.8-5.9] 1.9 [0.7-5.5] p=0.209
Neonatal ICU Admission 19% (46) 10% (1,364) 2.2 [1.6-3.0] 2.0 [1.4-2.8] p<0.001
13% (13) 19% (19) 30% (14)
Composite Fetal Outcome 39% (96) 18% (2,621) 2.3 [1.8-3.1] 1.9 [1.4-2.6] p<0.001
25% (25) 32% (32) 39% (19)

Data are presented as % (n), the mean ± SD and OR (95% CI). Gestational hypertension outcome included only for women without pre-existing hypertension. Outcomes are adjusted for age, race, BMI, diastolic blood pressure at first prenatal visit, history of diabetes and parity. P-values reflect the adjusted analysis for dichotomous outcome variables and t-tests between for continuous outcome variables entire r-AKI cohort and no AKI cohort. Numbers of perinatal deaths and birthweight < 3rd percentile in r-AKI group suppressed to preserve confidentiality due to low numbers.